Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
08/2010
08/17/2010US7776791 N-heterocyclyl phenyl-substituted cyclic ketoenols
08/17/2010CA2562104C Crystalline pyrazole derivative
08/12/2010WO2010090344A1 Hydrazide compound and use of the same in pest control
08/12/2010WO2010090304A1 Acylguanidine derivative
08/12/2010WO2010089210A1 Novel herbicides
08/12/2010WO2009109616A8 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
08/12/2010US20100204483 Process for preparing 2-dihaloacyl-3-aminoacrylic acid derivatives
08/12/2010US20100204472 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
08/12/2010US20100204284 Hetero-substituted acetanilide derivatives as analgesic agents
08/12/2010US20100204206 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
08/12/2010US20100199443 Yello anionic disazo dyes
08/12/2010CA2751440A1 Novel herbicides
08/12/2010CA2750324A1 Hydrazide compound and use of the same in pest control
08/11/2010EP2215908A1 2-Alkyl-cycloalk(en)yl-carboxamides and their use as fungizides
08/11/2010EP2215064A1 Compounds for inhibiting ksp kinesin activity
08/11/2010EP2215051A1 Fungicidal compounds, method for the production thereof, and use thereof to combat damaging fungi, and agents comprising the same
08/11/2010EP1756076B1 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
08/11/2010CN101801934A 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
08/11/2010CN101801384A methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
08/10/2010US7772404 Crystalline form 2 of the chemotherapeutic N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea
08/10/2010US7772269 Pyrazole analogs
08/10/2010US7772268 Diacyl indazole derivatives as lipase and phospholipase inhibitors
08/10/2010US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
08/10/2010US7772236 Substituted pyrazoles
08/10/2010US7772234 Bicyclic inhibitors of MEK and methods of use thereof
08/10/2010US7772232 Quinazolinyl compounds as inhibitors of potassium channel function
08/10/2010CA2462694C Neurotensin active 2,3-diaryl-pyrazolidine derivatives
08/10/2010CA2334399C Uracil compounds and use thereof
08/10/2010CA2249542C Pyrazole derivatives, their preparation and their use in pharmaceuticals
08/05/2010WO2010087770A1 Novel process for preparing carboxy-containing pyrazoleamido compounds 597
08/05/2010WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010WO2010087315A1 Anti-alzheimer’s disease agent
08/05/2010WO2010087313A1 Neurite elongation stimulator
08/05/2010WO2010087306A1 Anti-neurodegenerative disease agent
08/05/2010WO2010086311A1 Fungicide n-cycloalkyl-n-bicyclicmethylene-carboxamide derivatives
08/05/2010US20100197925 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives
08/05/2010US20100197924 Preparation of aminotetralin compounds
08/05/2010US20100197784 Novel curcumin analogues and uses thereof
08/05/2010US20100197753 Benzamides Useful as S1P Receptor Modulators
08/05/2010US20100197688 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
08/05/2010US20100197686 Therapeutic compounds
08/05/2010US20100197673 Indole and indazole compounds as an inhibitor of cellular necrosis
08/05/2010US20100197665 Indazole derivatives as kinase inhibitors for the treatment of cancer
08/05/2010US20100197644 Chemical Compounds 572
08/05/2010US20100197633 N-Alkyl-Heterocyclyl Carboxamide Derivatives
08/05/2010US20100192801 Novel Phenylpyrazolone Colorant
08/05/2010CA2750452A1 N-acyl anthranilic acid derivative or salt thereof
08/04/2010EP2212294A1 Process for making glucocorticoid receptor ligands
08/04/2010EP2212284A2 Calcium receptor modulating agents
08/04/2010CN101796026A Guanidine-containing compounds useful as muscarinic receptor antagonists
08/04/2010CN101796021A Processes for the preparation of pyrazoles
08/04/2010CN101792419A Synthetic method of compound blocked polyisocyanates by using multiple sealants to compound and block terminal groups
08/03/2010US7767827 reacting 3-hydroxypyrazole derivatives with dialkyl dicarbonates, hydrolysis; herbicides
08/03/2010US7767707 Fused pyrazolyl compounds having an aminoalkylcarbonyl group
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767705 Compounds that inhibit TRPV1 and uses thereof
08/03/2010US7767685 8-pyrazolo-xanthine derivatives such as 2-[3-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-5-methyl-pyrazol-1-yl]-N-phenyl-acetamide, used for treating asthma, rhinitis, dermatitis, diabetes, tumors, reperfusion injuries, inflammatory bowel disease, autoimmune diseases and vison defects
08/03/2010US7767674 Suppression cytokines, tumor necrosis factor
08/03/2010US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators
08/03/2010US7767626 3-arylphenyl sulfide derivative and insecticide and miticide
08/03/2010US7767625 Against phytopathogenic microorganisms, especially fungi, with a specific ortho, meta-disubstitution pattern; aniline precursors
08/03/2010US7767624 3-Heterocyclyl substituted benzoic acid derivatives
07/2010
07/29/2010WO2010020307A3 Indazole-5-carboxylic acid hydrazide derivatives
07/29/2010US20100190981 Processes for preparing jak inhibitors and related intermediate compounds
07/29/2010US20100190836 Compounds, Screens, and Methods of Treatment
07/29/2010US20100190827 treating diseases responsive to cannabinoid receptor antagonism; using particular crystallization conditions, a novel stable crystalline form called form II is obtained
07/29/2010US20100190780 Sigma receptor inhibitors
07/29/2010US20100190779 Viral polymerase inhibitors
07/29/2010US20100190777 Compounds and methods for kinase modulation, and indications therefor
07/29/2010US20100189648 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
07/28/2010EP2210892A2 Neurologically-active compounds
07/28/2010EP2029546B1 Aryl-substituted heterocycles, and use thereof
07/28/2010CN101786996A Amino acid and pesticide coupling compound as well as preparation method and application thereof as pesticide
07/28/2010CN101786991A Substituted tetracycline compounds
07/28/2010CN101133030B Menthane carboxamide derivatives having cooling properties
07/27/2010US7763641 such as [(1S,2R)-2-hydroxy-3-[N-[4-(2-methylaminothiazol-4-yl)phenylsulfonyl]-N-(2-methylpropyl)amino]-1-(phenylmethyl)propyl]carbamic acid, [(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl]ester, used for treating human immunodeficiency virus infections
07/27/2010US7763624 protein tyrosine kinase inhibitorssuch as 1-(but-3-enyl)-N3-(2,6-dimethylphenyl)-N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine, used for the treatment of autoimmune diseases and as antiproliferative or anticarcinogenic agents
07/27/2010CA2436659C Cannabinoid receptor ligands
07/22/2010WO2010083442A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010WO2010083441A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010WO2010083283A2 Processes for preparing jak inhibitors and related intermediate compounds
07/22/2010WO2010082044A1 Unsaturated bicyclic heterocyclic derivatives as smo antagonists
07/22/2010WO2010007046A3 Heteroaryl derivatives as dgat1 inhibitors
07/22/2010WO2009137339A3 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
07/22/2010US20100184995 Process for the production of a crystalline glucagon receptor antagonist compound
07/22/2010US20100184994 Method for Producing Difluoromethyl-Substituted Pyrazole Compounds
07/22/2010US20100184974 Protease Inhibitors
07/22/2010US20100184815 Agonists of peroxisome proliferator activated receptor-alpha
07/22/2010US20100184772 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators
07/22/2010US20100183712 Acylated indanyl amines and their use as pharmaceuticals
07/22/2010CA2749483A1 Processes for preparing jak inhibitors and related intermediate compounds
07/22/2010CA2747837A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010CA2747835A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/21/2010CN101784543A Indole and indazole compounds as an inhibitor of cellular necrosis
07/21/2010CN101784516A Dipeptide analogs as coagulation factor inhibitors
07/21/2010CN101133031B Method for producing 1-substituted-3-fluoroalkyl pyrazole-4-carboxylate
07/20/2010US7759497 Synthesis of diaryl pyrazoles
07/20/2010US7759382 such as N-{5-[1-(4-chloro-phenyl)-1-methyl-ethyl]-2H-pyrazol-3-yl}-2-[2-(3,5-difluoro-phenyl)-2-hydroxy-acetylamino]-propionamide, used for inhibiting beta-amyloid peptide release and/or biosynthesis, inhibiting gamma-secretase activity, prevention and treatment of Alzheimer's disease
07/20/2010US7759381 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
07/20/2010US7759380 Substituted pyrrolines as kinase inhibitors
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 256